logo
Six Massachusetts hospital workers on same floor report getting brain tumors

Six Massachusetts hospital workers on same floor report getting brain tumors

The Guardian16-04-2025
The number of staff members who have developed brain tumors while working on the same floor of a Boston-area hospital has increased to at least six, according to the facility's leadership.
A recent statement attributed to the president of Mass General Brigham's Newton-Wellesley hospital, Ellen Moloney, said the newly reported tumor was benign, as were five previously documented ones. The statement maintained that investigators had not turned up any evidence of environmental risks at the hospital, though their work remained ongoing.
Nonetheless, even before the number of staffers with tumors jumped, a labor union representing nurses at the hospital had pledged to press for answers.
That pledge came after Newton-Wellesley hospital's leadership initially confirmed that five nurses had reported developing non-cancerous growths in their brains after having worked on the facility's fifth-floor maternity unit at some point.
The sixth case – described as having been reported by a staffer rather than a nurse – was disclosed in the statement from Moloney, which the Boston.com news website first reported on.
An additional half-dozen staff members with experience working on the floor in question reported other health concerns that did not involve brain tumors, Newton-Wellesley officials have said.
The hospital has repeatedly suggested there is no evidence to establish that the situation is anything more than a coincidence – albeit one which was unusual enough to have captured attention on the national news and social media after word about it spread.
Moloney alluded to how the hospital had worked internal and governmental occupational offices while also consulting with outside environmental experts. Testing since then has examined the hospital's water, radiation levels, air quality and other factors, according to a 2 April memo from the facility.
'Based on the results of this rigorous ongoing investigation, we can assure you that no environmental risks have been identified at our hospital,' Moloney's more recent statement said.
The Massachusetts Nurses Association has said it is conducting its own investigation, despite the hospital's assurances.
The union argued that 'the hospital only spoke to a small number of nurses' and that the 'environmental testing was not comprehensive'.
Sign up to Headlines US
Get the most important US headlines and highlights emailed direct to you every morning
after newsletter promotion
The union told NBC10 Boston that it received more than 300 survey responses, emails, and telephone calls from nurses and other professionals working at the hospital – as well as from former employees.
Union officials reportedly said: 'It will take several weeks to sort through the information … vet it and obtain follow-up, including medical records, if respondents are willing to provide them.' They also said: 'The hospital cannot make this issue go away by attempting to provide a predetermined conclusion.'
Moloney's statement, for its part, alluded to 'a great deal of misinformation shared on social media and in other forums'.
'Health, wellbeing, and safety – along with that of our employees – remain our top priority,' Moloney's statement said. 'We want to make sure you have the facts.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NHS well prepared for influx in summer visitors in East Lindsey
NHS well prepared for influx in summer visitors in East Lindsey

BBC News

time2 days ago

  • BBC News

NHS well prepared for influx in summer visitors in East Lindsey

The NHS in Lincolnshire says it is well-prepared for the surge in summer visitors to the year the population of Skegness swells from 20,000 to around 250,000, due to tourists visiting the Neno from the Lincolnshire Integrated Care Board said it was "something we anticipate and plan for each year".The East Lindsey area enjoyed a record-breaking tourism year in 2024, with the seaside resorts and Lincolnshire Wolds receiving a total of 1.68 million summer visitors. "We are quite unique in the area with our summer surge of holidaymakers – most other places get a dip," Ms Neno to the Local Democracy Reporting Service, urgent treatment centres in Skegness, Louth and Boston Pilgrim Hospital are busier in the summer months than during the winter."We put a plan in place every year to make sure we're ready, and I have no concern about the negative impact of tourism."If anything, the number of visitors each summer is growing – the staycation boom after Covid hasn't dropped off in Lincolnshire."She said families with young children tend to see more minor illnesses, slips, trips and falls, "which can be easily dealt with"."Older people nowadays are typically living with more than one condition such as breathing problems, diabetes or frailty, which does put extra demand on community nurses and more urgent services," she biggest advice to holidaymakers is not to forget their medication, come with a First Aid kit and "behave as you would at home!" Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here. Download the BBC News app from the App Store for iPhone and iPad or Google Play for Android devices

Decade-long study finds link between this deficiency and dementia
Decade-long study finds link between this deficiency and dementia

The Independent

time4 days ago

  • The Independent

Decade-long study finds link between this deficiency and dementia

A decade-long study by Harvard Medical School scientists suggests that a deficiency of naturally occurring lithium in the brain could be a key factor in the development of Alzheimer's disease. Published in Nature, the research found that lithium loss is one of the earliest changes leading to Alzheimer's, with reduced levels observed in patients and accelerating memory decline in mice. Scientists discovered that a new compound, lithium orotate, can bypass amyloid plaques and effectively restore memory in mice at a significantly lower dose than traditional lithium treatments. The study utilised advanced mass spectroscopy to analyse metal levels in human brain and blood samples, revealing lithium as the only metal with markedly different levels across healthy individuals and those with varying stages of dementia. These findings offer a revised understanding of Alzheimer's, proposing a new strategy for early diagnosis, prevention, and treatment, though human clinical trials are still required to confirm the results.

Breakthrough study finds Alzheimer's could be due to this deficiency
Breakthrough study finds Alzheimer's could be due to this deficiency

The Independent

time4 days ago

  • The Independent

Breakthrough study finds Alzheimer's could be due to this deficiency

A deficiency of the metal lithium in the body could be a key factor contributing to the development of dementia in Alzherimer's patients, a groundbreaking new study reveals. The decade-long research, published in the journal Nature, shows for the first time that lithium occurs naturally in the brain and maintains the normal function of all its major cell types, preventing nerves from degradation. Scientists from Harvard Medical School found that lithium loss in the human brain is one of the earliest changes leading to Alzheimer's, while in mice, a similar lithium depletion accelerated memory decline. A reduced lithium level was found in some cases due to the metal's impaired uptake and its binding to amyloid plaques, which are known to be smoking gun signs of Alzheimer's. Researchers also showed that a new type of lithium compound – lithium orotate – can avoid capture by amyloid plaques and restore memory in mice. In the study, scientists used an advanced type of mass spectroscopy chemical analysis method to measure trace levels of about 30 different metals in the brain and blood samples from a range of people, including cognitively healthy people, those in an early stage of dementia, and those with advanced Alzheimer's. The analysis revealed that lithium was the only metal with markedly different levels across groups, which also seemed to change at the earliest stages of memory loss. 'Lithium turns out to be like other nutrients we get from the environment, such as iron and vitamin C,' study senior author Bruce Yankner said. 'It's the first time anyone's shown that lithium exists at a natural level that's biologically meaningful without giving it as a drug,' Dr Yankner said. Although lithium compounds have been historically in use to treat a range of mental conditions like bipolar disorder and major depressive disorder, in these cases, they are given at much higher concentrations that could even be toxic to older people. Scientists have now found that lithium orotate is effective at one-thousandth this dose – enough to mimic the natural level of lithium in the brain. The latest findings with lithium orotate, however, needs to be confirmed in humans via clinical trials. Yet, researchers suspect that measuring lithium levels could help screen people for early Alzheimer's. The findings revise the theory of Alzheimer's disease, which affects nearly 400 million people worldwide, offering a new strategy for early diagnosis, prevention, and treatment. Decades of studies have shown that Alzheimer's disease involves an array of brain abnormalities, including clumps of the protein amyloid beta, tangles of the protein tau, and a loss of the brain's protective protein REST. However, these abnormalities have never fully explained the condition. For instance, it remains unclear why some people with Alzheimer's-like changes in the brain never go on to develop dementia or cognitive decline. Recent treatments developed to target amyloid beta plaques also don't seem to reverse memory loss, only modestly reducing the rate of cognitive decline. Now, scientists say lithium could be the critical missing link. 'The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach,' Dr Yankner said. 'You have to be careful about extrapolating from mouse models, and you never know until you try it in a controlled human clinical trial... But so far the results are very encouraging,' he added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store